SCHEMBL6204827

SCHEMBL6204827

CS(=O)(=O)Oc1ccc2c(C(=O)c3ccc(OCCC4CCCCN4)cc3)c(-c3cc(F)c(F)c(F)c3CO)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.39
SSTR2 P30874 8/20 0.35
ENPP3 O14638 4/20 0.33
AURKB Q96GD4 1/20 0.32
ESR1 P03372 1/20 0.32
ENPP1 P22413 2/20 0.31
HRH4 Q9H3N8 1/20 0.31
LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203386 0.94 CHEK2 (0.39) CHEK2SSTR2ENPP3AURKBESR1
SCHEMBL6004786 0.88 CHEK2 (0.41) CHEK2SSTR2ENPP3AURKBESR1
SCHEMBL6203665 0.87 CHEK2 (0.40) CHEK2SSTR2ENPP3AURKBENPP1
SCHEMBL5417454 0.84 ENPP3 (0.48) ENPP3ESR1ENPP1
SCHEMBL6004833 0.84 CHEK2 (0.39) CHEK2SSTR2ENPP3AURKBESR1
SCHEMBL6004662 0.83 CHEK2 (0.39) CHEK2SSTR2ENPP3AURKBENPP1
SCHEMBL6005446 0.82 CHEK2 (0.44) CHEK2SSTR2AURKBESR1HRH4
SCHEMBL6004732 0.80 CHEK2 (0.43) CHEK2SSTR2AURKBESR1
SCHEMBL6005679 0.79 CHEK2 (0.44) CHEK2SSTR2AURKBESR1
SCHEMBL6005515 0.79 CHEK2 (0.42) CHEK2SSTR2AURKBESR1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551822-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2005-07-13 EP disclosed
WO-2004009578-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2004-01-29 WO disclosed